Landos Biopharma (NASDAQ: LABP)
|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
You can purchase shares of Landos Biopharma (NASDAQ: LABP) through any online brokerage.
The latest price target for Landos Biopharma (NASDAQ: LABP) was reported by Jefferies on Tuesday, April 12, 2022. The analyst firm set a price target for 1.40 expecting LABP to rise to within 12 months (a possible 100.17% upside). 8 analyst firms have reported ratings in the last year.
The stock price for Landos Biopharma (NASDAQ: LABP) is $0.6994 last updated May 20, 2022, 8:00 PM UTC.
There are no upcoming dividends for Landos Biopharma.
Landos Biopharma’s Q2 earnings are confirmed for Thursday, July 28, 2022.
There is no upcoming split for Landos Biopharma.
Landos Biopharma is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.